Cargando…
Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145267/ https://www.ncbi.nlm.nih.gov/pubmed/34094551 http://dx.doi.org/10.1002/ccr3.3164 |
_version_ | 1783697134937178112 |
---|---|
author | Liu, Qiuying (Selina) Ass'ad, Nour Ali Arana Yi, Cecilia |
author_facet | Liu, Qiuying (Selina) Ass'ad, Nour Ali Arana Yi, Cecilia |
author_sort | Liu, Qiuying (Selina) |
collection | PubMed |
description | Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment. |
format | Online Article Text |
id | pubmed-8145267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81452672021-06-03 Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review Liu, Qiuying (Selina) Ass'ad, Nour Ali Arana Yi, Cecilia Clin Case Rep Case Reports Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment. John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC8145267/ /pubmed/34094551 http://dx.doi.org/10.1002/ccr3.3164 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Liu, Qiuying (Selina) Ass'ad, Nour Ali Arana Yi, Cecilia Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title | Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title_full | Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title_fullStr | Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title_full_unstemmed | Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title_short | Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review |
title_sort | bosutinib‐associated interstitial lung disease and pleural effusion: a case report and literature review |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145267/ https://www.ncbi.nlm.nih.gov/pubmed/34094551 http://dx.doi.org/10.1002/ccr3.3164 |
work_keys_str_mv | AT liuqiuyingselina bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview AT assadnourali bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview AT aranayicecilia bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview |